Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Urology|July 24, 2007
Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?Peter J Bostrom, Mark S Soloway
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 9, 2016
Update on novel imaging techniques for the detection of lymph node metastases in bladder cancerAntti P Salminen, Ivan Jambor, Kari T Syvanen, et al.
Nature Reviews. Urology|May 19, 2010
Imaging renal cell carcinoma with ultrasonography, CT and MRIMichael J Leveridge, Peter J Bostrom, George Koulouris, et al.
The Journal of Urology|November 13, 2007
Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomyPeter J Bostrom, Mark S Soloway, Murugesan Manoharan, et al.
World Journal of Urology|July 20, 2012
Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocolsNathan Perlis, Polat Turker, Peter J Bostrom, et al.
BJU International|May 4, 2012
Does patient age affect survival after radical cystectomy?David Horovitz, Polat Turker, Peter J Bostrom, et al.
Virchows Archiv : an International Journal of Pathology|June 2, 2014
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancerYann Neuzillet, Bas W G van Rhijn, Nadia L Prigoda, et al.
Journal of the American Medical Informatics Association : JAMIA|August 6, 2011
Point-of-care clinical documentation: assessment of a bladder cancer informatics tool (eCancerCareBladder): a randomized controlled study of efficacy, efficiency and user friendliness compared with standard electronic medical recordsPeter J Bostrom, Paul J Toren, Hao Xi, et al.
European Urology Oncology|September 10, 2020
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell TumorGregory J Nason, Michael A S Jewett, Peter J Bostrom, et al.
Urology Annals|October 7, 2011
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, et al.
Pageof 3